Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Emine Nilufer Guler"'
Autor:
Mehmet Ali Kaplan, Sevil Bavbek, Ozkan Alan, Gokhan Demir, Pinar Saip, Yesim Eralp, Semra Paydas, Nazım Serdal Turhal, Atakan Demir, Necdet Uskent, Özlem Sönmez Uysal, Emine Nilufer Guler, Adnan Aydiner, Kadri Altundag, Taner Korkmaz, Hacer Demir, Mustafa Teoman Yanmaz, Ismail Beypinar, Başak Oyan Uluç, Şeyda Gündüz, Sadettin Kilickap, Polat Olgun, Nil Molinas Mandel, Murat Sari, Ozlem Er, Nuri Karadurmuş, G. Basaran, Meral Gunaldi
Publikováno v:
Balkan Medical Journal, Vol 37, Iss 2, Pp 104-107 (2020)
Balkan Medical Journal
Balkan Medical Journal
WOS:000518031100008 PMID: 31970972 Background: The synthesis of CDK4/6 inhibitors with endocrine treatment in two series of treatment has been widely accepted as the standard for patients with estrogen receptor-positive metastatic breast cancer. In s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::576c9e9e2e79553b07d5cdb6f07501c4
https://doaj.org/article/04ceb2349b6c44ffbafb27dfc640256d
https://doaj.org/article/04ceb2349b6c44ffbafb27dfc640256d
Autor:
Engin Ok, Kezban Nur Pilanci, Emine Nilufer Guler, Abdurrahman Isikdogan, Cetin Ordu, Oben Duman, Halil Kara, Bahadır Öz, Pinar Saip, Cihan Uras, Vahit Ozmen, Ajlan Atasoy, Ozturk Ates, Erhan Gokmen, Fatma Sen, Mustafa Ozdogan, Orhan Demircan
Publikováno v:
Journal of Clinical Oncology. 33:e11515-e11515
e11515 Background: The 21-gene Oncotype DX assay is accepted as an important predictive factor in the adjuvant treatment of node negative, estrogen receptor (ER) positive and HER2 (-) breast cancer...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::151473e5dfd1d7d4083bc580d08d666e
https://doi.org/10.1200/jco.2015.33.15_suppl.e11515
https://doi.org/10.1200/jco.2015.33.15_suppl.e11515
Autor:
Atakan Demir, Nil Molinas Mandel, Semra Paydas, Gökhan Demir, Özlem Er, Nazım Serdal Turhal, Sevil Bavbek, Yeşim Eralp, Pınar Mualla Saip, Emine Nilüfer Güler, Adnan Aydıner, Başak Oyan Uluç, Sadettin Kılıçkap, Necdet Üskent, Nuri Karadurmuş, Mehmet Ali Kaplan, Mustafa Teoman Yanmaz, Hacer Demir, Özkan Alan, Taner Korkmaz, Polat Olgun, Özlem Sönmez Uysal, Kadri Altundağ, Şeyda Gündüz, Meral Günaldı, Murat Sarı, İsmail Beypınar, Gül Başaran
Publikováno v:
Balkan Medical Journal, Vol 37, Iss 2, Pp 104-107 (2020)
Background:The synthesis of CDK4/6 inhibitors with endocrine treatment in two series of treatment has been widely accepted as the standard for patients with estrogen receptor-positive metastatic breast cancer. In spite of this, the activity of CDK4/6
Externí odkaz:
https://doaj.org/article/04ceb2349b6c44ffbafb27dfc640256d
Autor:
Ibrahim Gullu, Sercan Aksoy, Yavuz Ozisik, Emine Nilufer Guler, Kadri Altundag, Mehmet Ali Nahit Sendur
Publikováno v:
Journal of Clinical Oncology. 31:e11553-e11553
e11553 Background: Systemic chemotherapy is often ineffective due to the impermeability of the blood-brain barrier (BBB) and inherent chemoresistance of CNS metastases. There are limited data supporting the use of capecitabine in this setting. The ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ef8fad80aac9e65b03115eca2e70577
https://doi.org/10.1200/jco.2013.31.15_suppl.e11553
https://doi.org/10.1200/jco.2013.31.15_suppl.e11553
Publikováno v:
BMC Cancer
BMC Cancer, Vol 6, Iss 1, p 37 (2006)
BMC Cancer, Vol 6, Iss 1, p 37 (2006)
Background The hereditary hemochromatosis gene HFE plays a pivotal role in iron homeostasis. The association between cancer and HFE hetero- or homozygosity has previously been shown including hepatocellular and nonhepatocellular malignancies. This st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03c7d768b8211c1aef00e4225e07645b
http://europepmc.org/articles/PMC1402308
http://europepmc.org/articles/PMC1402308